---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-24-000694"
form_type: "8-K"
ticker: "ZIVO"
cik: "0001101026"
company_name: "Zivo Bioscience, Inc."
filed_at: "2024-01-17T23:59:59+00:00"
generated_at: "2026-06-06T22:25:21.053515+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Zivo Bioscience sells 174,145 unregistered shares to accredited investors at avg $3.05/share

## Summary
- Sold 174,145 common shares at $2.82–$4.02 each (avg $3.05), relying on Section 4(2) and Regulation D.
- No underwriter discounts or commissions; transaction exempt from registration under Securities Act.
- As of Jan 16, 2024, outstanding common shares totaled 2,748,167.

## SEC filing metadata
- accession: 0001654954-24-000694
- form_type: 8-K
- ticker: ZIVO
- cik: 0001101026
- company_name: Zivo Bioscience, Inc.
- filed_at: 2024-01-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1101026/000165495424000694/0001654954-24-000694-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1101026/000165495424000694/zivo_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-24-000694
- JSON: https://secwatch.observer/filing/0001654954-24-000694.json
- Plain text: https://secwatch.observer/filing/0001654954-24-000694.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.